The future of precision oncology looks promising, with ongoing advancements in genomics, bioinformatics, and artificial intelligence. These technologies will enhance our ability to analyze and interpret vast amounts of genetic data, leading to more effective and precise treatments. As our understanding of cancer biology deepens, new targets for therapy will emerge, and personalized treatment plans will become increasingly sophisticated. The integration of precision oncology into standard clinical practice will likely improve patient outcomes and revolutionize cancer care.
